How much revenue does OssDsign AB (publ) make?

OssDsign AB (publ) reported 180.16 million SEK in revenue for fiscal year 2025, up 34.5% from 133.94 million SEK in fiscal year 2024. In Q1 2026 revenue was 36.88 million SEK.

What companies are similar to OssDsign AB (publ)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Bactiguard Holding AB (publ) (BACTI-B.ST), FluoGuide A/S (FLUO.ST), Senzime AB (publ) (SEZI.ST), SciBase Holding AB (publ) (SCIB.ST).

OssDsign AB (publ) (OSSD.ST) Stock

About OssDsign AB (publ)

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.

At a glance

OssDsign AB (publ) reported revenue of 180.16 million SEK for fiscal year 2025, up 34.5% from fiscal year 2024, and net income of -50.99 million SEK. In Q1 2026 (the quarter ended March 31, 2026) revenue was 36.88 million SEK, down 17.1% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.